Training in FDG-PET/CT advances lung cancer outcome
September 16, 2019 -- Additional training in FDG-PET/CT to monitor concurrent chemotherapy for patients with stage III non-small cell lung cancer can significantly extend both overall and progression-free survival, according to an international study published in the October issue of European Journal of Nuclear Medicine and Molecular Imaging.  Discuss
Swiss cast new light on prostate cancer analysis
September 16, 2019 -- Researchers from Zurich have found gallium-68 prostate-specific membrane antigen offers better sensitivity, while multiparametric MRI provides better specificity, especially when determining tumor cell spread beyond the lymph node capsule or when prostate cancer extends into the seminal vesicles.  Discuss
Novel PET method advances in traumatic brain injury
September 13, 2019 -- A research team from the U.K. and Sweden has used dynamic flortaucipir-PET imaging to show that single moderate-to-severe traumatic brain injury can trigger signs of accumulation of neurodegenerative tau protein and lead to cognitive decline.  Discuss
Ga-68 PMSA PET/CT aids in prostate cancer recurrence
September 12, 2019 -- Italian researchers have created a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT-based model to accurately predict which prostate cancer patients are likely to show recurrence. Their study was published on 6 September in the European Journal of Nuclear Medicine and Molecular Imaging.  Discuss
Merging PET and MRI assists in large-vessel vasculitis
September 12, 2019 -- French investigators have combined contrast-enhanced anatomic assessments of MRI with the quantitative measurement of FDG uptake in PET to accurately characterize and differentiate between inflammation and fibrosis in the aortic walls and auxiliary branches of patients with large-vessel vasculitis.  Discuss
ESR seeks to demystify biomarkers
September 9, 2019 -- The European Society of Radiology (ESR) has issued a detailed set of recommendations designed to promote the use of validated imaging biomarkers as clinical decision-making tools. Prof. Nandita deSouza explains the rationale behind this initiative.  Discuss
ESC: Cancer cases rise in developed world
September 3, 2019 -- Fresh statistics presented at this week's European Society of Cardiology (ESC) congress in Paris confirm that cancer is now the leading cause of death in high-income countries, while heart disease burden persists in less prosperous countries.  Discuss
U.K. groups seek urgent answers on radioisotopes
August 2, 2019 -- Radiology and nuclear medicine groups have urged U.K. Prime Minister Boris Johnson to provide some answers to outstanding questions about radioisotope supply ahead of a potential no-deal Brexit. They've demanded assurances about product supply and costs to the National Health Service.  Discuss
PET/MRI develops growing role in cervical cancer
July 22, 2019 -- PET/MRI can become an increasingly valuable modality for the early-stage diagnosis of cervical cancer, especially when the disease spreads to the parametrium, according to a study published on 17 July in the European Journal of Radiology.  Discuss
PET makes progress in determining Alzheimer's risk
July 22, 2019 -- A Swedish-led group has developed a novel technique that uses florbetapir-PET scans for tracking beta-amyloid accumulation in adults to gauge the risk of progression to Alzheimer's disease. The investigators published their findings online on 17 July in JAMA Neurology.  Discuss